MARK2 and lung cancer: LIMK1 is a serine/threonine kinase associated with the cytoskeletal structure in many cellular processes, and may have importance in the sensitivity of lung cancer and osteosarcoma cells to chemotherapy treatment (Chen et al. 2013; Zhang et al. 2011).